Reducing the maternal mortality rate due to postpartum haemorrhage depends on the ability of health-care teams to identify pregnant women at higher risk of bleeding, to timely and accurately detect ...

The average analyst rating for the stock is buy. AFRM underperformed the S&P 500 index by -15.0% during today's afternoon ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

SPDR® S&P Insurance ETF outperforms the market, with a 10% YTD gain. Find out why KIE’s strong valuation and cyclical ...

First Digital USD (FDUSD) crashed and de-pegged as low as 13% after Justin Sun claimed its issuer, First Digital Trust, did ...

I think these Footsie and FTSE 250 growth shares could be very shrewd buys to consider in the current climate. Here's why.

Vertex Pharmaceuticals has analysts doing financial backflips as they boost its price targets, with Royal Bank of Canada ...

Assets jumped 51%, staff more than doubled, and the cost of running the $97 billion pension fund remained enviably low. At 37 ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Raspberry Pi shares offer something a little different for UK-focused investors. But while the minicomputer company surged after IPO, it’s slumped in 2025.